0000911420-24-000063.txt : 20240315 0000911420-24-000063.hdr.sgml : 20240315 20240315101346 ACCESSION NUMBER: 0000911420-24-000063 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20240315 DATE AS OF CHANGE: 20240315 EFFECTIVENESS DATE: 20240315 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HCG FUNDS LTD. CENTRAL INDEX KEY: 0001623764 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-283301 FILM NUMBER: 24752919 BUSINESS ADDRESS: STREET 1: 133 FAYETTEVILLE STREET STREET 2: SUITE 300 CITY: RALEIGH STATE: NC ZIP: 27601 BUSINESS PHONE: 919-300-7702 MAIL ADDRESS: STREET 1: 133 FAYETTEVILLE STREET STREET 2: SUITE 300 CITY: RALEIGH STATE: NC ZIP: 27601 D/A 1 primary_doc.xml X0708 D/A LIVE 0001623764 HCG FUNDS LTD. 133 FAYETTEVILLE STREET SUITE 300 RALEIGH NC NORTH CAROLINA 27601 919-300-7702 CAYMAN ISLANDS None None Other Cayman Islands Exempted Company true Thomas Hanson HCG Funds Ltd. Waystone,Ste 5B201,2ndFlr 1 Nexus Way Camana Bay, Grand Cayman E9 CAYMAN ISLANDS KY1 1103 Director Nicole Ramroop HCG Funds Ltd. Waystone,Ste 5B201,2ndFlr 1 Nexus Way Camana Bay, Grand Cayman E9 CAYMAN ISLANDS KY1 1103 Director Hadi F. Habal HCG Funds Ltd. 133 Fayetteville Street, Suite 300 Raleigh NC NORTH CAROLINA 27601 Director Executive Officer Director of HCG Funds Ltd. and CEO of HCG Fund Management, Investment Adviser of Issuer Pooled Investment Fund Other Investment Fund false Decline to Disclose 3C.7 06b 3C true 0001567619-23-005086 2015-06-01 true true true true Equity consisting of participating, redeemable shares. Issuer has the discretion to accept a lesser minimum investment amount from investors, subject to Cayman law or regulation. false 1000000 Indefinite 20324118 Indefinite false 41 0 0 160789 true Affiliates (GP and/or Investment Manager) of the Issuer, and/or persons named in Item 3 may, from time to time, receive certain management fees and expense reimbursements deemed to be made from the proceeds of the offering. HCG FUNDS LTD. /s/ Hadi F. Habal Hadi F. Habal Director of Issuer and CEO of Investment Adviser of Issuer 2024-03-15